...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Inhibition of endoplasmic reticulum stress-activated IRE1 alpha-TRAF2-caspase-12 apoptotic pathway is involved in the neuroprotective effects of telmisartan in the rotenone rat model of Parkinson's disease
【24h】

Inhibition of endoplasmic reticulum stress-activated IRE1 alpha-TRAF2-caspase-12 apoptotic pathway is involved in the neuroprotective effects of telmisartan in the rotenone rat model of Parkinson's disease

机译:内质网应激激活的IRE1α-TRAF2-caspase-12凋亡途径的抑制与替米沙坦在帕金森氏病鱼藤酮大鼠模型中的神经保护作用有关

获取原文
获取原文并翻译 | 示例
           

摘要

Telmisartan, one unique angiotensin II type 1 receptor blocker, has been attracting attention due to its putative peroxisome proliferator-activated receptor (PPAR)-gamma or beta/delta actions. Recently, telmisartan has been reported to exert neuroprotective effects in animal models of Parkinson's disease (PD). However, the underlying mechanisms have not been fully clarified. Recently, accumulating evidence has shown that endoplasmic reticulum (ER) stress plays a crucial role in rotenone-induced neuronal apoptosis. Additionally, studies have revealed that inositol-requiring enzyme/endonuclease 1 alpha (IRE1 alpha) is necessary and sufficient to trigger ER stress. In the present study, we aimed to determine whether ER stress-activated IRE1 alpha-mediated apoptotic pathway is involved in the neuroprotection of telmisartan in the rotenone rats of PD and explore the possible involvement of PPAR-beta/delta activation. The catalepsy tests were performed to test the catalepsy symptom. The dopamine content and alpha-synuclein expression were ascertained through high-performance liquid chromatography and immunohistochemistry, respectively. The expression of IRE1 alpha, TNF receptor associated factor 2 (TRAF2), caspase-12 and PPAR-beta/delta was detected by western blot. Neuronal apoptosis was assessed by TUNEL and immunohistochemistry. Our results show that telmisartan ameliorated the catalepsy symptom and attenuated dopamine depletion as well as alpha-synuclein accumulation. Moreover, telmisartan decreased ER stress-mediated neuronal apoptosis. Furthermore, telmisartan inhibited IRE1 alpha-TRAF2-caspase-12 apoptotic signaling pathway. Additionally, telmisartan activated PPAR beta/delta, implying that PPAR-beta/delta activation properties of telmisartan are possibly or partially involved in the neuroprotective effects. In conclusion, our findings suggest that suppressing ER stress-activated IRE1 alpha-TRAF2-caspase-12 apoptotic pathway is involved in the neuroprotective effects of telmisartan in the rotenone rats of PD. (C) 2016 Elsevier B.V. All rights reserved.
机译:替米沙坦是一种独特的1型血管紧张素II受体阻滞剂,由于其假定的过氧化物酶体增殖物激活受体(PPAR)-γ或β/δ作用而受到关注。最近,据报道替米沙坦在帕金森氏病(PD)的动物模型中发挥神经保护作用。但是,底层机制尚未完全阐明。最近,越来越多的证据表明内质网(ER)应激在鱼藤酮诱导的神经元凋亡中起着至关重要的作用。此外,研究表明,需要肌醇的酶/核酸内切酶1 alpha(IRE1 alpha)足以触发ER应激。在本研究中,我们旨在确定ER应激激活的IRE1α介导的细胞凋亡途径是否与PD鱼藤酮大鼠中替米沙坦的神经保护有关,并探讨PPAR-β/δ激活的可能参与。进行僵直测试以测试僵直症状。通过高效液相色谱和免疫组织化学分别确定多巴胺含量和α-突触核蛋白的表达。 Western blot检测IRE1α,TNF受体相关因子2(TRAF2),caspase-12和PPAR-β/δ的表达。通过TUNEL和免疫组织化学评估神经元凋亡。我们的结果表明,替米沙坦改善了僵直症状,减轻了多巴胺的消耗以及α-突触核蛋白的积累。此外,替米沙坦可减少内质网应激介导的神经元凋亡。此外,替米沙坦抑制IRE1α-TRAF2-caspase-12凋亡信号通路。另外,替米沙坦激活了PPARβ/δ,这意味着替米沙坦的PPAR-β/δ激活特性可能或部分参与了神经保护作用。总之,我们的发现表明,抑制ER应激激活的IRE1α-TRAF2-caspase-12凋亡途径与替米沙坦对PD鱼藤酮大鼠的神经保护作用有关。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号